BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27280110)

  • 21. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
    Chandrasekhar J; Baber U; Sartori S; Faggioni M; Aquino M; Kini A; Weintraub W; Rao S; Kapadia S; Weiss S; Strauss C; Toma C; Muhlestein B; DeFranco A; Effron M; Keller S; Baker B; Pocock S; Henry T; Mehran R
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):629-637. PubMed ID: 27152497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in Japan.
    Hosaka A; Miyata T; Onishi Y; Liao L; Zhang Q
    Clin Ther; 2014 Aug; 36(8):1223-30, 1230.e1-4. PubMed ID: 25012730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression and long-term prognostic outcomes following peripheral endovascular interventions in the VA Healthcare System.
    Smolderen KG; Plomondon ME; Armstrong EJ; Hess E; Waldo S; Tsai TT; Maddox TM
    Vasc Med; 2018 Oct; 23(5):454-460. PubMed ID: 29801427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial.
    Ferrante G; Presbitero P; Corrada E; Campo G; Bolognese L; Vassanelli C; Colangelo S; De Cesare N; E Rodriguez A; Bramucci E; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Ferrari R; Valgimigli M
    Am Heart J; 2012 Jan; 163(1):104-11. PubMed ID: 22172443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
    Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
    Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in health status and adverse outcomes among patients with peripheral arterial disease.
    Dreyer RP; van Zitteren M; Beltrame JF; Fitridge R; Denollet J; Vriens PW; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2014 Dec; 4(1):e000863. PubMed ID: 25537275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
    Sposato LA; Lam M; Allen B; Shariff SZ; Saposnik G;
    Stroke; 2020 Feb; 51(2):387-394. PubMed ID: 31914883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.
    Welten GM; Schouten O; Hoeks SE; Chonchol M; Vidakovic R; van Domburg RT; Bax JJ; van Sambeek MR; Poldermans D
    J Am Coll Cardiol; 2008 Apr; 51(16):1588-96. PubMed ID: 18420103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting.
    Mehilli J; Kastrati A; Dirschinger J; Bollwein H; Neumann FJ; Schömig A
    JAMA; 2000 Oct; 284(14):1799-805. PubMed ID: 11025832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis.
    Ortmann J; Nüesch E; Cajöri G; Diehm N; Dick F; Traupe T; Baumgartner I
    J Vasc Surg; 2011 Dec; 54(6):1668-78. PubMed ID: 22035761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very long-term outcome of peripheral arterial disease in patients undergoing percutaneous coronary revascularization: a retrospective analysis.
    Pullara A; D'Ascenzo F; Gonella A; Moretti C; Sciuto F; Omedè PL; Bollati M; Biondi Zoccai G; Gaita F; Sheiban I
    Minerva Cardioangiol; 2012 Dec; 60(6):553-60. PubMed ID: 23147433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
    Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
    JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States.
    Khera S; Kolte D; Gupta T; Subramanian KS; Khanna N; Aronow WS; Ahn C; Timmermans RJ; Cooper HA; Fonarow GC; Frishman WH; Panza JA; Bhatt DL
    J Am Coll Cardiol; 2015 Nov; 66(18):1961-1972. PubMed ID: 26515998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of gender on outcomes after lower extremity revascularization.
    Wang J; He Y; Shu C; Zhao J; Dubois L
    J Vasc Surg; 2017 Mar; 65(3):889-906.e4. PubMed ID: 28236929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.